Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Stock Market News Today Live Updates: Nifty Slips Below 24,050 Amid F&O Expiry, Sensex Falls Over 150 Points; Vedanta Slides 5% After Block Deals
Nifty IT and Nifty Metal fell 1.22% each, leading losses among sectoral indices. Nifty Pharma rose 0.90%, while Nifty Media gained 0.52% and Nifty India Defence advanced 0.33%.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.

KIMS launches ₹1,500 crore QIP to repay debt and fund subsidiaries
KIMS has launched a ₹1,500 crore qualified institutions placement (QIP) through a 100% primary share issuance, with the indicative price set at ₹755 per share at up to a 3% discount to the last closing price. The hospital chain plans to use the proceeds to repay debt and fund investments in its subsidiaries, with the issue expected to be priced later this week and listed on the NSE and BSE thereafter.

Nifty 50 target cut by Citi to 26,000 - Key risk factors, top picks explained
Citi has highlighted Financials, Telecom, Healthcare, Defence and Utilities as their key "overweights", while IT Services, Staples, Metals are their top "underweights." It has also added Hitachi Energy into its list of top picks having initiated coverage on the stock recently.

Buy, Sell Or Hold: IRCTC, SBI, Hindustan Copper, M&M, Paras Defence, Dr Reddy's Laboratories — Ask Profit
Buy Sell Hold
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

Himalaya Wealth launches ₹500 crore SME fund to back manufacturing, deeptech firms
The Category I AIF will target profitable growth-stage SMEs in sectors including aerospace, defence, industrial automation and healthcare, amid rising investor interest in manufacturing-led businesses.

Cotec Healthcare, Deepa Jewellers receive SEBI's nod to float IPOs
Cotec Healthcare and Deepa Jewellers get SEBI approval for IPOs, plan fresh issues and OFS to fund capacity expansion, working capital and general corporate needs, to list on BSE and NSE

PM Modi In Europe: From Trade Deal, Defence To Tech — Here's What To Expect
The third India-Nordic Summit will take place on May 19.